European Bioanalysis Forum: Dried blood spot (DBS) microsampling consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2011
  • Initiating Organization: European Bioanalysis Forum
  • Initiator Type: Third-party organization
  • No disease focus


Since 2008, the European Bioanalysis Forum (EBF) has engaged its members and the broader bioanalytical community in discussions and surveys on the bioanalytical applications and challenges for dried blood spots (DBS). In 2011, EBF presented its Recommendation Paper on the validation of bioanalytical methods for DBS. In addition, EBF hosted separate symposia on DBS, or assigned sessions in the technology at its Open Symposia to ensure the connection of all scientists interested or involved. EBF also connected to an initiative within the International Consortium on Innovation and Quality in Pharmaceutical Development (IQ) to ensure synergy in the global discussions on DBS.


Bioanalysis and DBS became part of EBF’s agenda of EBF in June 2008 and have been repeatedly discussed ever since that first presentation in Basel. A full conference session was dedicated to DBS during the 2009 open EBF conference in Barcelona, and a 1.5-day workshop is currently in preparation. 

Consortium History

June 17-18, 2010: Held conference, “Connecting Strategies on Dried Blood Spots,” in Brussels, Belgium


Points of Contact

Communication with EBF should be directed to the Steering Committee:
Margarete Brudny-Kloeppel, Bayer Schering Pharma AG, Germany
Arjen Companjen, Crucell, Netherlands
Michaela Golob, Merck-Serono, Germany
Philip Timmerman, Janssen Research & Development, Belgium
Peter van Amsterdam, Abbott Healthcare Products, Netherlands
Steve White, GSK, United Kingdom

The EBF Steering Committee can be mailed at
For financial/administrative matters use:


Sponsors & Partners

Actelion Ltd


Boehringer Ingelheim


Johnson & Johnson

Solvay Pharmaceuticals/Abbott

Last Updated: 04/15/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.